ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how our rules link it today.

4 links0 made here, not in the record5 judgments1 judge (our rules as one)0 record changes seen
Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04344158A Phase III Clinical Trialof AK105 Injection CombinedWith AnlotinibHydrochloride CapsulesVersus Sorafenib inSubjects With AdvancedHepatocellular CarcinomaChia Tai Tianqing PharmaceuticPhase 3 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSCarcinoma, HepatocellularNo longer in the registry's filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionDRUGSPenpulimabEntry “AK105 Injection”, read by our …›As of now · Our role rule · TestedTestedCatequentinib hydrochlorideEntry “Anlotinib Hydrochloride Capsul…›As of now · Our role rule · TestedTestedSorafenibEntry “Sorafenib Tosylate Tablets”, r…›As of now · Our role rule · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Carcinoma, Hepatocellular

From the registry record2 judgments on this link
Kind of condition link, from the registry to what was judged
RegistryCarcinoma, Hepatocellular, once filedthe registry files the study under it
→judged
Main condition (R9)
→
On the pageNo longer linkedthe registry no longer files it here

All judgments on this study

WhenLinkJudgeDecisionState
Nov 14Carcinoma, HepatocellularOur condition-kind ruleFinest filed termCurrent
As of nowCarcinoma, HepatocellularOur main-condition rule (R9)Main conditionCurrent
As of nowPenpulimabOur role ruleTestedCurrent
As of nowCatequentinib hydrochlorideOur role ruleTestedCurrent
As of nowSorafenibOur role ruleComparatorCurrent